IMRT Reirradiation of Head and Neck Cancer—Disease Control and Morbidity Outcomes

This publication has 34 references indexed in Scilit:

• Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Results of Radiation Therapy Oncology Group Protocol 9911
  Journal of Clinical Oncology, 2007
• Salvage Re-Irradiation for Recurrent Head and Neck Cancer
  International Journal of Radiation Oncology*Biology*Physics, 2007
• Locally Recurrent, Previously Irradiated Head and Neck Cancer: Concurrent Re-Irradiation and Chemotherapy, or Chemotherapy Alone?
  Journal of Clinical Oncology, 2006
• Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer
  Head & Neck, 2005
• Intensity‐modulated radiation therapy in head and neck cancers: An update
  Head & Neck, 2005
• Randomized Phase III Evaluation of Cisplatin Plus Fluorouracil Versus Cisplatin Plus Paclitaxel in Advanced Head and Neck Cancer (E1395): An Intergroup Trial of the Eastern Cooperative Oncology Group
  Journal of Clinical Oncology, 2005
• Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience
  Annals of Oncology, 2004
• Phase 1 trial of combined chemotherapy and reirradiation for recurrent unresectable head and neck cancer
  Head & Neck, 2002
• Salvage Surgery for Patients With Recurrent Squamous Cell Carcinoma of the Upper Aerodigestive Tract: When Do the Ends Justify the Means?
  The Laryngoscope, 2000
• The reirradiation of recurrences of head and neck cancer
  The British Journal of Radiology, 1980